Early increase in tamoxifen dose in CYP2D6 poor metaboliser breast cancer patients and survival: A propensity score matching analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Early increase in tamoxifen dose in CYP2D6 poor metaboliser breast cancer patients and survival: A propensity score matching analysis

Published:2023-06 Issue: Volume:69 Page:342-348
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Blancas Isabel^ORCID,Linares-Rodríguez Marina,Martínez de Dueñas Eduardo,Herrero-Vicent Carmen,Molero-Mir María D.,Garrido José M.,Rodríguez-Serrano Fernando

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference39 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;Ca - Cancer J Clin,2021

2. Tamoxifen treatment and gynecologic side effects: a review;Mourits;Obstet Gynecol,2001

3. Tamoxifen as the first targeted long-term adjuvant therapy for breast cancer;Jordan;Endocr Relat Cancer,2014

4. Tamoxifen: a personal retrospective;Jordan;Lancet Oncol,2000

5. Tamoxifen in the treatment of breast cancer;Osborne;N Engl J Med,1998

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nonlinear Mixed‐Effects Model of Z‐Endoxifen Concentrations in Tamoxifen‐Treated Patients from the CEPAM Cohort;Clinical Pharmacology & Therapeutics;2024-03-18

2. Impact of CYP2D6, CYP2C9/19, CYP3A4, UGT, and SULT Variability on Tamoxifen Metabolism in Breast Cancer Treatment;Journal of Current Oncology;2024-02-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP